<bill session="116" type="h" number="3772" updated="2020-10-13T14:15:11Z">
  <state datetime="2019-07-16">REFERRED</state>
  <status>
    <introduced datetime="2019-07-16"/>
  </status>
  <introduced datetime="2019-07-16"/>
  <titles>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.</title>
    <title type="short" as="introduced">Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019</title>
    <title type="short" as="introduced">Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019</title>
    <title type="display">Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019</title>
  </titles>
  <sponsor bioguide_id="P000608"/>
  <cosponsors>
    <cosponsor bioguide_id="B001303" joined="2020-07-27"/>
    <cosponsor bioguide_id="B001284" joined="2020-01-24"/>
    <cosponsor bioguide_id="B001309" joined="2019-10-22"/>
    <cosponsor bioguide_id="H001065" joined="2019-07-16"/>
    <cosponsor bioguide_id="K000391" joined="2019-11-29"/>
    <cosponsor bioguide_id="K000382" joined="2020-06-25"/>
    <cosponsor bioguide_id="L000582" joined="2019-09-06"/>
    <cosponsor bioguide_id="L000565" joined="2019-10-31"/>
    <cosponsor bioguide_id="L000579" joined="2020-02-04"/>
    <cosponsor bioguide_id="M000312" joined="2019-09-20"/>
    <cosponsor bioguide_id="M001196" joined="2019-11-08"/>
    <cosponsor bioguide_id="M001210" joined="2020-05-19"/>
    <cosponsor bioguide_id="P000604" joined="2020-10-09"/>
    <cosponsor bioguide_id="P000616" joined="2019-11-26"/>
    <cosponsor bioguide_id="P000599" joined="2020-07-30"/>
    <cosponsor bioguide_id="R000610" joined="2020-09-08"/>
    <cosponsor bioguide_id="R000616" joined="2019-11-08"/>
    <cosponsor bioguide_id="R000515" joined="2019-07-16"/>
    <cosponsor bioguide_id="R000609" joined="2020-02-21"/>
    <cosponsor bioguide_id="S001185" joined="2020-03-11"/>
    <cosponsor bioguide_id="S001208" joined="2019-11-08"/>
    <cosponsor bioguide_id="S001200" joined="2019-11-08"/>
    <cosponsor bioguide_id="W000813" joined="2020-07-16"/>
    <cosponsor bioguide_id="W000822" joined="2019-12-16"/>
  </cosponsors>
  <actions>
    <action datetime="2019-07-16">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-07-16" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-07-16">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-07-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Health care costs and insurance"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Home and outpatient care"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2019-07-16T04:00:00Z" status="Introduced in House">Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.</summary>
  <committee-reports/>
</bill>
